INMD · InMode Ltd.

Track INMD — free

$14.90 +0.13 (+0.88%) At close · Sep 11

Rebalance outlook locked

Market Cap

$857.41M

57.54M

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

—

Trailing 12 months

Net income (TTM)

—

Trailing 12 months

Revenue growth YoY

-6.2%

Year over year

Operating margin

23.0%

Trailing 12 months

P / E (TTM)

—

Trailing earnings

FCF yield

—

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

-18.8%

Year over year · fewer shares

Price change (1Y)

-1.7%

Trailing year

Short interest

4.1%

Latest settlement · 5.6 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Neutral Momentum Neutral Sentiment Neutral Fundamentals Fair Quant / Vol Low

Market backdrop VIX 15.8 · calm Equity put/call 0.58

Technical

price trend

Neutral

50 / 200-day cross No cross

Price vs 200-day avg +4%

above

Price vs 50-day avg −1%

below

RSI (14) 48

neutral

MACD trend Negative

52-week position 55%

mid-range

Momentum

relative strength

Neutral

1-month return −2%

trailing

6-month return +10%

trailing

YTD return +1%

this year

Relative strength −8%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $15 › 200d $14 — 50d above 200d

Institutional flow Distributing

-3% holders QoQ · +37 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

4.08% of float · ▼ -3.4% MoM · 5.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr low

189 holders — near 3-yr low, contrarian setup

Squeeze score 58

elevated · 0–100

Fundamentals

Fair

Revenue growth −6%

Y/Y

Gross margin 79%

contracting

EPS growth −36%

Y/Y

Free cash flow $84.3M

Quant / Vol

risk profile

Low

Volatility 32%

annualized · 1-yr

Max drawdown −23%

past year

ATR 1.5%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Beat or met 2 of last 2

Latest guidance · from the Earnings Call filed Mar 31, 2026

Revenues · 2026 $365M – $375M

prior FY $370.5M midpoint −0.1% Y/Y

Non-GAAP gross margin · 2026 Non-GAAP 74% – 76%

Prior guidance period ended · from the Earnings Call filed Sep 30, 2021

China revenue (quarterly run-rate) · next year $4M

Guided vs delivered · last 2 settled

China revenue (quarterly run-rate) next year

guided $4M

guided $4M $454.27M Beat +11256.8%

Total revenue full-year 2021

guided $305M – $315M

guided $305M – $315M $357.57M Beat +15.3%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral

1 · 4 · 1

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+4% Bullish

Price vs 50-day avg

−1% Neutral

RSI (14)

48 Neutral

MACD trend

Negative Bearish

52-week position

55% Neutral

Market signals — smart money & positioning

Mixed

Trend (MA cross) No cross

50d $15 › 200d $14 — 50d above 200d

Institutional flow Distributing

-3% holders QoQ · +37 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

4.08% of float · ▼ -3.4% MoM · 5.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr low

189 holders — near 3-yr low, contrarian setup

Price context

position in its 52-week range

Range low $13 Now $15 · 55% Range high $17

vs 200-day avg +4% vs 50-day avg -1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
INMD InMode Ltd. this stock	$857.41M	+1.4%	-6.2%	—	4.1%
ABT Abbott Laboratories	$177.58B	-18.6%	+5.7%	28.6	1.3%
MDT Medtronic plc	$116.35B	-5.3%	+8.4%	22.4	0.9%
SYK Stryker Corp	$105.70B	-21.6%	+11.2%	28.6	2.0%
BSX Boston Scientific Corp	$62.29B	-54.9%	+12.5%	17.4	3.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

189

% held: 57.0%
Net QoQ: -1.8M sh
Top holder: Doma Perpetual Capital Ma…

Held Float

View

Held by Funds

Fund positions

View

Short & Settlement

Short Interest Falling

Shares short

2.3M

Days to cover: 5.6d
Change: -83.3K sh

View

Short Volume

Short vol %

48%

As of: Sep 11, 2026

Short Total

View

Fails to Deliver

FTD shares

881

Value: $13.4K
As of: Aug 14, 2026

View

Off-Exchange

Off-exchange %

43.7%

Week of: Aug 3, 2026

Off-exch Lit

View

Financials

Revenue (FY)

$370.5M

Net income (FY): $197.9M
EPS diluted: $1.43

View

Filings

SEC Filings

Latest

6-K

Filed: Aug 11, 2026
This year: 18

View

Proposed Sales

Value

$6.4M

Shares: 150.0K
Filed: Aug 1, 2023

View

Earnings & Events

Earnings Calls

Last call

Jun 3, 2026

View

Performance

Raw-price comparisons begin at the captured split on Oct 1, 2021; windows that need an earlier baseline remain unavailable.

	5D	20D	120D	MTD	YTD
INMD	+0.4%	-2.0%	+10.1%	-0.4%	+1.4%
SPY	-1.2%	-1.8%	+17.8%	-0.4%	+12.1%
vs SPY	+1.6%	-0.2%	-7.7%	0.0%	-10.7%

Key facts CIK 1742692 CUSIP M5425M103 13F (30d) 61 filings 61 filers Visit website Investor relations

INMD · InMode Ltd.

Price & Indicators

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Versus peers

At a glance

Performance